Immusoft
PrivateLast Round
Grant
Mar 30, 2026
Total Funding Raised
$53.85M
Company Overview
Immusoft is a biotechnology company that creates innovative therapies for rare diseases through autologous cell therapies utilizing immune system programming technology to transform patients' B cells into antibody-producing biofactories.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immusoft Comps
Public and private peers based on sector, stage, and business model.
Immusoft Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 30, 2026 | ||||
| Grant | Jan 27, 2023 | ||||
| Grant | Nov 29, 2021 | ||||
| Series B | Jan 3, 2019 | ||||
| Grant | Sep 5, 2018 | ||||
Series A | Nov 1, 2016 |
Immusoft Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mesa Verde Venture Partners | Series B |
| Thiel Foundation | Grant |
| NIH RADx | Grant |
| Founders Fund | Series B, Series A |
| 600 Mile Challenge Fund | Series B |
| Breakout Ventures | Series B |
| California Institute for Regenerative Medicine | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 30, 2026
$15M grant funding secured.
- May 13, 2025
Will present data at the ASGCT 2025 event.
Immusoft Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Immusoft's valuation, stock price, and market status.
